Yasuhiro Fujisawa Selected Research

Stewart Treves syndrome

8/2015	Long-term control of pleural metastasis in Stewart-Treves syndrome with single-agent chemotherapies followed by maintenance chemotherapy.
1/2011	Intra-arterial mitoxantrone/paclitaxel in angiosarcoma of the lower limb associated with chronic lymphedema (Stewart-Treves syndrome) in a patient with cervical cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yasuhiro Fujisawa Research Topics

Disease

38	Melanoma (Melanoma, Malignant) 08/2022 - 10/2006
20	Neoplasms (Cancer) 08/2021 - 04/2009
11	Neoplasm Metastasis (Metastasis) 01/2021 - 07/2012
7	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2021 - 11/2006
7	Hemangiosarcoma (Angiosarcoma) 01/2021 - 01/2011
6	Dermatitis 01/2022 - 04/2017
6	Skin Neoplasms (Skin Cancer) 01/2020 - 01/2011
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 11/2013
5	Extramammary Paget Disease (Paget Disease, Extramammary) 01/2019 - 11/2015
4	Inflammation (Inflammations) 01/2022 - 03/2011
4	Dermatomyositis (Dermatopolymyositis) 10/2021 - 03/2008
3	Fever (Fevers) 08/2019 - 06/2016
3	Disease Progression 08/2019 - 05/2017
3	Carcinoma (Carcinomatosis) 12/2018 - 11/2011
3	Pituitary Neoplasms (Pituitary Adenoma) 11/2013 - 07/2012
2	Carcinogenesis 01/2022 - 05/2013
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 12/2019
2	Actinic Keratosis 04/2021 - 05/2013
2	Bowen's Disease (Disease, Bowen) 04/2021 - 05/2013
2	Lymphatic Metastasis 01/2021 - 10/2016
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 09/2013
2	Necrosis 01/2021 - 07/2008
2	Vitiligo 06/2020 - 02/2017
2	Bullous Pemphigoid (Pemphigoid) 06/2020 - 06/2006
2	Stewart Treves syndrome 08/2015 - 01/2011
2	Pemphigus (Pemphigus Vulgaris) 01/2007 - 06/2006
1	Contact Dermatitis (Eczema, Contact) 01/2022
1	Erythema 10/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 09/2021
1	Ulcer 04/2021
1	Diabetes Mellitus 04/2021
1	Cryopyrin-Associated Periodic Syndromes 02/2021
1	Alopecia Areata 01/2021
1	Atrophy 01/2021
1	Cystadenocarcinoma 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Brain Neoplasms (Brain Tumor) 10/2020
1	Esophagitis 08/2020
1	Pancytopenia 06/2020
1	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 06/2020

Drug/Important Bio-Agent (IBA)

21	NivolumabIBA 05/2021 - 01/2016
13	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2016
9	IpilimumabIBA 01/2021 - 11/2017
8	AntibodiesIBA 08/2022 - 01/2018
7	Biomarkers (Surrogate Marker)IBA 12/2020 - 04/2017
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 01/2018
4	pembrolizumabIBA 06/2020 - 01/2018
4	LigandsIBA 12/2019 - 01/2016
3	Imiquimod (Aldara)FDA LinkGeneric 01/2022 - 01/2020
3	AutoantibodiesIBA 01/2021 - 06/2006
3	Granzymes (Granzyme)IBA 01/2021 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 10/2020 - 04/2017
3	Proteins (Proteins, Gene)FDA Link 01/2020 - 10/2016
3	Programmed Cell Death 1 ReceptorIBA 05/2019 - 01/2018
3	SteroidsIBA 04/2019 - 11/2017
3	Docetaxel (Taxotere)FDA Link 06/2016 - 09/2012
3	Transcription Factors (Transcription Factor)IBA 11/2013 - 03/2011
3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 06/2013 - 01/2011
3	Fluorouracil (Carac)FDA LinkGeneric 02/2009 - 11/2006
2	trametinibIBA 12/2021 - 08/2019
2	dabrafenibIBA 12/2021 - 08/2019
2	InterferonsIBA 08/2021 - 05/2017
2	PerforinIBA 01/2021 - 01/2016
2	Immunoglobulin G (IgG)IBA 01/2021 - 01/2007
2	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2011
2	AllergensIBA 01/2020 - 12/2019
2	Prednisolone (Predate)FDA LinkGeneric 08/2019 - 04/2019
2	Monoclonal AntibodiesIBA 05/2019 - 06/2016
2	HLA Antigens (Human Leukocyte Antigens)IBA 10/2018 - 01/2016
2	eribulin FDA Link 06/2018 - 01/2018
2	human ERBB2 proteinIBA 05/2018 - 10/2016
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2017 - 11/2013
2	Coloring Agents (Dyes)IBA 06/2013 - 07/2012
2	AntigensIBA 11/2010 - 04/2009
2	Cisplatin (Platino)FDA LinkGeneric 02/2009 - 11/2006
1	DinitrofluorobenzeneIBA 01/2022
1	calcipotriene (calcipotriol)FDA LinkGeneric 01/2022
1	loricrinIBA 01/2022
1	Ligases (Synthetase)IBA 10/2021
1	apremilastIBA 08/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 08/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2021
1	encorafenibIBA 03/2021
1	binimetinibIBA 03/2021
1	canakinumab FDA Link 02/2021
1	AutoantigensIBA 01/2021
1	tofacitinibIBA 01/2021
1	transcriptional intermediary factor 1IBA 01/2021
1	Interferon Type IIBA 01/2021
1	Bexarotene (LGD1069)FDA Link 06/2020
1	Immunoglobulins (Immunoglobulin)IBA 06/2020
1	Ferrochelatase (Heme Synthetase)IBA 04/2020

Therapy/Procedure

28	Therapeutics 08/2022 - 11/2006
11	Immunotherapy 09/2021 - 04/2009
11	Drug Therapy (Chemotherapy) 01/2021 - 03/2014
4	Lymph Node Excision (Lymph Node Dissection) 08/2016 - 11/2011
2	Chemoradiotherapy 01/2019 - 01/2018
2	Maintenance Chemotherapy 01/2018 - 08/2015
1	Ambulatory Surgical Procedures (Outpatient Surgery) 04/2021
1	Hematopoietic Stem Cell Transplantation 01/2021